XML 13 R2.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Balance Sheets - USD ($)
Mar. 31, 2019
Dec. 31, 2018
Current assets    
Cash and cash equivalents $ 5,535,000 $ 8,157,000
Prepaid expenses and other current assets 407,000 251,000
Total current assets 5,942,000 8,408,000
Property and equipment, net 420,000 503,000
In-process research and development 2,731,000 2,731,000
Acquired patents, net 238,000 245,000
Right-of-use asset 286,000  
Total assets 9,617,000 11,887,000
Current liabilities    
Accounts payable and accrued liabilities 1,757,000 1,220,000
Accrued compensation 1,834,000 1,352,000
Total current liabilities 3,591,000 2,572,000
Derivative liabilities 33,000 22,000
Deferred tax liability 819,000 819,000
Other long-term liabilities 213,000  
Total liabilities 4,656,000 3,413,000
Stockholders' equity    
Common stock, $0.01 par value; 67,000,000 shares authorized at September 30, 2018 and December 31, 2017; 16,468,308 and 9,498,928 shares issued and outstanding at September 30, 2018 and December 31, 2017, respectively 328,000 323,000
Additional paid-in capital 414,566,000 414,467,000
Accumulated deficit (409,933,000) (406,316,000)
Total stockholders' equity 4,961,000 8,474,000
Total liabilities and stockholders' equity $ 9,617,000 $ 11,887,000